Sedaject 0.5 mg Solution is a Health Canada–registered veterinary drug (DIN 02492431) held by Grey Wolf Animal Health Inc, containing Dexmedetomidine Hydrochloride. Health Canada lists its status as Marketed (status date 22 Jan 2021). Nexara Health has matched 309 registrations of Dexmedetomidine Hydrochloride across 24 other regulated markets.

Health Canada registration

Dexmedetomidine Hydrochloride registered in other markets

309 registrations of the same molecule in 24 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Dexmedetomidine Hydrochloride worldwide →

Regulator price references for Dexmedetomidine Hydrochloride

Published list or reimbursement prices for Dexmedetomidine Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Sedaject (DIN 02492431) marketed in Canada?

Yes. Health Canada lists DIN 02492431 as Marketed as of 22 Jan 2021.

Who holds the Canadian licence for this product?

Grey Wolf Animal Health Inc is the company of record in the Health Canada Drug Product Database.

Is Dexmedetomidine Hydrochloride registered outside Canada?

Yes — Nexara Health has matched 309 registrations in 24 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02492431, status date 2021-01-22; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, NPRA, SFDA, SUKL DLP, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02492431, status date 2021-01-22; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, NPRA, SFDA, SUKL DLP, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, SFDA.

Health Canada Drug Product Database (DPD), DIN 02492431, status date 2021-01-22; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, NPRA, SFDA, SUKL DLP, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.